This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovations of Shoji Fujitani
Introduction
Shoji Fujitani is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medical science, particularly in the area of cancer research. His work focuses on developing innovative solutions to combat liver cancer, a critical health issue affecting many individuals.
Latest Patents
Fujitani holds a patent for an inhibitor for liver cancer onset and progress. This invention provides a prophylactic or therapeutic agent, a pharmaceutical composition, and a health-promoting food aimed at inhibiting the onset or progress of liver cancer. The active ingredients in this invention include isoleucine, leucine, and valine, with a preferred weight ratio of 1:1.5 to 2.5:0.8 to 1.7. The recommended daily dose ranges from 2.0 g to 50.0 g, showcasing the potential of this invention in cancer prevention and treatment.
Career Highlights
Fujitani is associated with Ajinomoto Co., Ltd., a company known for its commitment to health and nutrition. His work at Ajinomoto has allowed him to focus on innovative research that addresses significant health challenges. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medical science.
Collaborations
Fujitani has collaborated with notable colleagues such as Kiwamu Okita and Isao Sakaida. These partnerships have fostered a collaborative environment that enhances the research and development of effective health solutions.
Conclusion
Shoji Fujitani's contributions to the field of liver cancer research exemplify the impact of innovation in medicine. His work not only highlights the importance of scientific research but also offers hope for improved health outcomes in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
